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INTRODUCTION
    Pain has become the fifth vital sign and is now a critical focus of the patient. The 
relief of pain has always been part of anaesthesiologist’s role. In the immediate post 
operative  period  and  extending  beyond  post  anaesthesia  care  unit.  There  is  also 
increasing evidence that optimal pain management can impact outcome beyond the intra 
operative period. Alleviation of post operative pain may continue to improve clinical 
outcomes, hasten recovery, facilitate early mobilization and return to daily living.
The treatment and alleviation of pain is a basic human right. Children suffer pain 
in  the same way as adults  though they may be unable to describe the pain or  their 
subjective  experiences.  Unfortunately  even  when  their  pain  is  obvious  children 
frequently receive no treatment or inadequate treatment.
PAIN is a perception that is far more complex than simple transmission of information 
along nerve pathways to brain. 
It  consists  of  component  of  transmission  of  pain  sensation,  a  component  of 
processing and evaluation by higher centers of brain and a component of reaction to 
sensation.
The response to PAIN in children consists of behavioral, psychological and social 
changes.  The  cognitive  ability,  child’s  trust  of  caregivers  and  previous  painful 
experiences will influence this response.
 The manner in which the family reacts to the stress of a child’s pain will also 
influence the response to pain.  Appropriate pain management is  of great importance 
when dealing with children, because the way the child is treated may influence the way 
he/she deals with pain for rest of his /her life. 
Untreated Pain can lead to physiologic complications, psychological distress, and 
personality changes in developing children, family disruption, interruption of hospital 
routine and prolongation of hospitalization with resultant increased costs.  In addition 
social  withdrawal,  temper  tantrums and demanding behaviour are  also seen in these 
children.  Children  withdraw  from  their  environment  and  stop  participating  in 
interpersonal interactions.
 Various  pharmacological  agents  and  analgesic  delivery  systems  have  been 
employed to avoid under treatment of pain in children. Many children will withdraw or 
deny their pain in an attempt to avoid yet another terrifying and painful experience-the 
intramuscular injection or “shot”.
Genito  urinary  surgery  is  generally  associated  with  considerable  pain  of  long 
duration.
 Caudal extradural block with bupivacaine ensures satisfactory analgesia in the 
initial post operative period only, and becomes ineffective once the block wears off.
Various methods have been devised to extend the duration of regional analgesia 
with local anaesthetics. Like placement of a catheter and using adjuvants like, clonidine, 
tramadol, ketamine and opioids.The placement of a catheter posses an inherent risk of 
infection and delays mobilization.
The use of ketamine, clonidine and opioids is limited because of potential side 
effects such as sedation, respiratory depression, nausea and vomiting.
The role of neostigmine as an analgesic administered by the extra dural route is 
now well established in children and adults. Co administration of caudal neostigmine in 
a dosage of 2µg/kg with bupivacaine or ropivacaine has been found to prolong analgesia 
without any adverse effect.
Extra dural neostigmine (1, 2 or 4µg/kg) with local anaesthetic has been found to 
produce a  dose independent  analgesic  effect  in  adult  patients  without  increasing  the 
incidence of adverse effects.
AIM OF THE STUDY
A study of the effect of caudal epidural neostigmine for relief of post operative pain in 
children undergoing lower abdominal general surgical procedures.
ANATOMY OF THE CAUDAL EPIDURAL SPACE
SACRAL HIATUS
It is a bony defect, triangular in shape and situated at the lower end of the sacrum 
just  above the sacrococcygeal junction. The hiatus results from non-fusion of the 5th 
sacral and at times 4th sacral vertebral arches. It appears as an inverted U or V; the large 
bony processes on each side are called the cornua. The sacral cornua are in fact the 
embryological remains of the inferior articular processes of the 5th sacral vertebrae. The 
hiatus is covered by the sacrococcygeal membrane formed by the superficial and deep 
fibers of sacrococcygeal ligaments and is attached laterally to sacral cornua.
The sacrococcygeal membrane is actually a continuation of ligamentum flavum. 
The sacrum is cartilaginous in neonates and infants, and its ossification is completed 
between 25 to 30 years of age. At increasing age, the sacrococcygeal angle increases, 
thus closing sacral hiatus and therefore making caudal anaesthetic more difficult. This is 
especially true after the age of 7 years.
SACRAL CANAL AND THE CAUDAL EPIDURAL SPACE
The  sacral  canal  is  a  caudal  extension  of  the  spinal  canal.  The  spinal  canal 
contains the last spinal nerve roots, which forms the cauda equina and also the filum 
terminale that anchors spinal cord to coccyx and sacrococcygeal ligament. The dural sac 
projects upto S3 - S4 level at birth, reaching the adult level of S2 during second year of 
life.
The caudal epidural space in a neonate is filled with epidural fat, which has a 
gelatinous spongy appearance with distinct spaces between the fat globules and very few 
connective tissue fibers. This facilitates uniform and rapid spread of the local anaesthetic 
solutions. Between 6 to 7 years of age, the epidural fat gets denser and is surrounded by 
fibrous strands, thus reducing uniform spread of local anaesthetic solutions. The epidural 
space  is  richly  vascularised  and  the  veins  are  without  valves;  thus  an  inadvertent 
intravascular   injection can lead to instantaneous systemic toxicity.
          
Caudal anaesthesia requires identification of the sacral hiatus. The sacrococcygeal 
ligament overlying the sacral hiatus lies between the sacral cornu. To facilitate locating 
the cornu,  the posterior  superior  iliac spine should be located and by using the line 
between  them  as  one  side  of  an  equilateral  triangle,  the  location  of  sacral  hiatus 
approximated. After the sacral hiatus is identified the index and middle finger of the 
palpating hand are placed on the sacral cornu, and the caudal needle is inserted at an 
angle  of  approximately  45  degrees  to  the  sacrum.  While  advancing  the  needle,  a 
decrease in resistance to needle insertion should be appreciated as the needle enters the 
caudal  space.  The  needle  is  advanced  until  bone  is  contracted  and  then  slightly 
withdrawn, and the needle is redirected so that the angle of insertion relative to the skin 
surface is decreased. In male patients this angle is almost parallel to the coronal plane, in 
female patients, a slightly steeper angle (15 degree) is necessary. During redirection of 
the  needle  and  after  loss  of  resistance  again  encountered,  the  needle  is  advanced 
approximately 1 to 2 cm into the caudal canal.
FIG -1
COMPLICATIONS OF CAUDAL ANAESTHESIA
Intravascular  or  intraosseous  injection:-This  may  lead  to  grand  mal  seizure  and 
cardio respiratory arrest.
Dural puncture: Extreme care must be taken to avoid this as a total spinal block will 
occur if a dose for a caudal block is injected into the subarachnoid space.
Perforation  of  the  rectum: While  simple  needle  puncture  is  not  important, 
contamination of the needle is extremely dangerous if it is then inserted into the epidural 
space.
Sepsis: This should be very rare occurrence if strict aseptic procedures are followed
Urinary  retention:  This  is  not  uncommon  and  temporary  catheterization  may  be 
required
Subcutaneous injection: This should be obvious as the drug is injected
Hematoma:
Absent or patchy block:
PHARMOCOLOGY OF BUPIVACAINE
The pharmacology of local anaesthetics is generally the same in children as it is in 
adults. There are differences like
1. Increased volume of distribution
2. Decreased protein binding of local anaesthetics
3. Enzyme immaturity
Decreased protein binding of local anaesthetics and enzyme immaturity can lead to 
systemic toxicity of local anaesthetics with high protein affinity.
Caudal injections of bupivacaine are now routinely used in children undergoing lower 
abdominal and urogenital surgery to provide intraoperative and postoperative analgesia. 
BUPIVACAINE
It is an amide local anaesthetic characterized as pipecoloxylidides. Addition of a 
butyl group to the piperidine nitrogen of mepivacaine results in Bupivacaine. It is 
a chiral drug because of possession of asymmetric carbon atom.
It was first synthesized in Sweden by EKENSTAM and his colleagues in 1957 and used 
clinically by L.J.TELIVUO in 1963. Its molecular weight is 288.
MECHANISM OF ACTION 
It prevents transmission of nerve impulses by inhibiting passage of sodium ions 
through ion selective sodium channels in nerve membranes. They do not alter the resting 
transmembrane potential or threshold potential.
PHARMACOKINETICS
 It is a weak base that has pk value above physiologic pH.  At pH 7.4 only 15% 
exists in nonionised form. Absorption depends on the site of injection, dosage and use of 
epinephrine. Lung is capable of extracting bupivacaine from circulation, which will limit 
concentration  of  drug  that  reaches  systemic  circulation.  This  first  pass  pulmonary 
extraction is dose dependent suggesting that it becomes saturated rapidly.
 pk                                                       :          8.1
Protein Binding                                   :          95%
Lipid solubility                                    :          28
Volume of distribution                       :          73 litre
Clearance of drug from plasma          :          0.471 lit/min
Elimination half life                           :          210 min   (3.5 hours)
Onset time                          : 5 -7 min
t ½ α                            :          2.7 min
t ½ β                           :          28 min
METABOLISM 
 Slowest  metabolism  among  amide  local  anaesthetics.  It  undergoes  aromatic 
hydroxylation, N- dealkylation, amide hydrolysis and conjugation. Only the N-desbutyl 
bupivacaine has been measured in blood or urine after epidural or spinal anaesthesia. 
Alpha-1 acid glycoprotein is the most important protein-binding site of bupivacaine.
SIDE EFFECTS
Bupivacaine is more cardio toxic than equieffective doses of   Lignocaine. This is 
manifested by severe ventricular arrhythmias and myocardial depression. Bupivacaine 
blocks cardiac Na+ channels rapidly during systole and dissociates more slowly during 
diastole, so that a significant fraction of Na+ channels remain blocked at the end of the 
diastole. Thus the block by Bupivacaine is cumulative and substantially greater.
CLINICAL USE
Onset of anaesthesia and duration of action are long. Its tendency to provide more 
sensory than motor block has made it  popular for providing postoperative analgesia. 
Used mainly for
o Infiltration anaesthesia   
o Field block anaesthesia
o Nerve block anaesthesia
o Spinal anaesthesia
o Epidural anaesthesia
RECOMMENDED DOSE
   Bupivacaine without epinephrine     – 2.5 mg/Kg
   Bupivacaine with epinephrine          – 3 mg/Kg
TOXIC PLASMA CONCENTRATION THRESHOLD
- 2 µg / ml
PHARMOCOLOGY OF NEOSTIGMINE METHYL SULPHATE
Acschlimam and Reinert synthesized neostigmine methyl sulphate in 1931.Anti 
curare action were discovered by Pal in 1900.
It prevents normal hydrolysis of Acetyl choline and so allows it to accumulate at neuro 
muscular junction. It is a standard antagonist to d-tudocurarine or other non depolarizing 
muscle relaxants.
PHARMACOLOGICAL ACTIONS
CNS: 
By  inhibiting  normal  hydrolysis  of  acetyl  choline  at  the  sites  at  which  it  is 
released,neostigmine raises the concentration and duration of action of acetyl choline.
Neuraxial neostigmine is known to produce analgesia in animals, human volunteers and 
patients with pain.
Neuraxial administration of neostigmine inhibits breakdown of the endogenous 
spinal neurotransmitter acetyl choline, which has been shown to produce analgesia.
The  analgesic  effect  is  thought  to  be  mediated  via  spinal  muscarinic  (M1) 
receptors A dose response study of caudal neostigmine has proved its efficacy and safety 
in  paediatric  patients.  Dose  dependant  analgesia  has  been  observed  with  caudal 
neostigmine in the range of 20-50µg/kg.
A  single  caudal  injection  of  neostigmine  2µg/kg  when  added  to  bupivacaine 
0.25% or ropivacaine 0.2% has been found to provide an extended duration of post 
operative analgesia.(~ 20-22 hrs), and reduced the need for supplementary analgesics in 
children undergoing genitourinary surgery. 
Respiratory depression, sedation and pruritis ascribed to the use of caudal opioids 
are not encountered with caudal neostigmine.
Furthermore  in  contrast  to  clonidine  its  use  with  local  anaesthetics  is  not 
associated with significant haemodynamic changes.
 This is attributed to ability of neostigmine to counteract the sympathetic block of 
spinal bupivacaine on the sympathetic nervous system,
There by blunting the hypotension induced by neuraxial local anaesthetics and 
clonidine.
The  main  adverse  effects  reported  with  the  use  of  neuraxial  neostigmine  are 
nausea and vomiting.
Although the incidence has been reported to be significantly higher with the intra 
thecal route, use of extradural neostigmine in adults and children has been found to be 
associated with a lower incidence of nausea and vomiting.. It does not cross the blood 
brain barrier as it is a quaternary ammonium compound and hence no action on central 
nervous system when given intravenously.
ANS:
On autonomic nervous system it has both muscarinic and nicotinic actions. 
Nicotinic actions at the level of autonomic ganglia and skeletal muscle. muscarinic 
receptors present at lacrimal,salivary and gastric gland. Bronchial, gastro intestinal, and 
bladder Smooth muscle cells and SA and AV nodes of the heart.
CVS:
Peripheral vagal  stimulation will  cause bradycardia,  cardiac dysrrhythmias and 
cardiac arrest may follow with large doses.
RS: 
Increases secretion of tracheo bronchial tree and produces broncho constriction.
SMOOTH MUSCLE:
 Increases peristalsis, miosis, prevents constipation and atony of urinary bladder.
DOSE: 
0.04-0.08 mg/kg for reversal of non depolarizing blockade. 2µg-4µg /kg caudally along 
with local anaesthetics.
METABOLISM:
 A  small  portion  is  excreted  by  glomerular  filtration  via  kidneys  and  similar 
portion is destroyed in liver.
SIDE EFFECTS:
Restlessness, weakness, muscular twitching, dysarthria, pinpoint pupils, 
nystagmus, sweating, increased salivation, nausea ,vomiting, abdominal colic, urination 
and sudden cardiac arrest due to rapid administration.
CALCULATION OF THE VOLUME OF LOCAL           ANAESTHETIC FOR 
CAUDAL ANAESTHESIA
Many formulas based on weight, age and number of spinal segments to be blocked and 
the parameter  ’D’ (Distance from C7 to sacral Hiatus) have been used to determine the 
dose of local anaesthetic required.
SPIEGEL et al (6) described a formula to calculate the total volume of Bupivacaine (V) 
depending on the distance separating the sacral hiatus from the spinous process of the 7th 
cervical vertebra as follows 
                    V = 4 + (D-15)/2 
   V-Volume of local anaesthetic 
  D- Distance from C7 to sacral Hiatus
BROMAGE  PR  et  al  (8)  proposed  a  formula  to  determine  the  volume  of  local 
anaesthetics to be injected into the caudal epidural space depending on the age of the 
patient and per spinal segment.
V = 0.106 + (0.075 X Age in years)
V-Volume of local anaesthestic 
TAKASAKI M et al (9) suggested a calculation depending on the weight of the patient 
in kg.
V = 0.056 ml X Body weight (in kg) X number of spinal segments to be blocked.
SCHULTE  –  STEINBERG  examined  the  statistical  influence  of  age,  weight  and 
height on caudal dose requirements before puberty. He found that the pattern of spread 
was highly predictable in children. The relationship between age and dose requirements 
was strictly linear = 0.1 ml / segment / year of age.
V is volume in ml of 1% lignocaine or 0.25% bupivacaine.
In practice, however, it is easier to use the formula describes by ARMITAGE EN et al 
(10)
LUMBOSACRAL                        0.5 ml/kg
THORACOLUMBAR                  1 ml/Kg
MIDTHORACIC                          1.25 ml/Kg
Of 0.25% bupivacaine.
Armitage formula was used in this study. This formula is easy to use, 
reliable and safe in children.
ASSESSMENT OF PAIN IN CHILDREN
Children present problems of assessment of pain when compared with adults because of 
their lower level of verbal fluency and the likelihood that varied development levels 
alter their understanding of questions or tests. Hence assessment of pain proved difficult 
in  children.  Assessment  and  management  are  interrelated.  Unfortunately  validated 
totally  acceptable  tools  for  measuring  pain  in  children  are  not  available.  Various 
methods are available as per Brown TCK. (11)
1. Physiological measurements
2. Self report techniques
3. Behavioural  assessment
PHYSIOLOGICAL MEASUREMENTS
Changes  in  pulse,  blood  pressure  and  respiration  reflect  autonomic  arousal. 
Autonomic responses to pain and their measurement form an important aspect of certain 
pain  scales.  Metabolic  changes  cause  release  of  catecholamine,  growth  hormone, 
glucagons, cortisol, aldosterone and beta-endorphins, which have been documented in 
infants and children following 
noxious  stimulation.  Only  plasma  cortisol  has  been  shown  to  correlate  with 
behavioural responses to noxious stimuli.
SELF REPORT TECHNIQUES 
As described by Manuksela et al, (12) these are the best indicators of a child’s 
subjective experience. Various methods have been used:
(a) VISUAL ANALOGUE SCALE  (13)
 The accepted method of measurement of pain in adults is acceptable and provides 
reproducible results in children down to an age of five years. VAS using a 10 cm length 
scale marked “no pain” at one to “worst pain possible” at the other end. The child is 
asked to  identify  a  point  on  the  scale,  which  corresponds  to  his  pain.  The  point  is 
measured from the left hand end and reported in mm from 0 to 100 or in cm from 0 to 
10. A score of less than 4 is no pain, less than 6 implies tolerable pain and more than 6 
means he needs medication. 
(b) OUCHER SCALE  (14)
It  is  a  variant  of  the faces scale  and is  designed to  measure pain intensity  in 
children aged 3 to 12 years. The scale is displayed in a poster format. It consists of a 
vertical numerical scale (0 to 100) on the left and six photographs of children in varying 
degrees  of  pain  positioned  vertically  to  the  right.  This  scale  is  based  on  mimic, 
vocalization and irritability. Characteristics of increasing pain are:
(1)Distortion of face such as lowering of the brow, broadening of the nasal root, 
angular and squarish mouth, tightly closed eyes and tightening of the jaw.
(2)Vocalization, changing from sobbing or groaning to cry.
(C) WONG – BAKER FACES PAIN RATING SCALE (15)
It is recommended for persons of age three and more. It contains six different 
faces of expression varying from a happy to sad mood. The patient has to be explained 
that each face is for a person who feels happy because he has no pain (hurt) or sad 
because  he  has  some or  a  lot  of  pain.  Ask the patient  to  choose  the face  that  best 
describes how he is feeling.  
A similar  scale  was designed by  Daiva Bieri et  al  (16) to assess  pain in  the 
Children’s  Hospital,  University  of  Helsinki.  This  scale  was  based  on  mimic, 
vocalization, movements or rigidity of the limbs and the body, response to handling and 
irritability together with the measured cardioventilatory parameters. 
BEHAVIOURAL ASSESSMENT
This method of assessment relies on observation of behaviour and is more useful 
in the pre-school age group of children. They score the behaviour, which represent the 
reaction  to  pain  and  scores  are  allotted  according  to  the  degree  of  alteration  of  a 
particular behaviour .The behavioural score include vocal behaviour such as cry, scream, 
verbally expressed pain and anxiety and nonverbal behaviour such as muscle rigidity, 
torso movements, leg movements, facial expression.
(1) THE PBRS: Pain  behaviours  rating  scale  and Children’s  Hospital  of  Eastern 
Ontario pain scale -  CHEOPS (58)  are the two such scales. The observation in 
these scales can have an observer bias.
(2)THE  OBJECTIVE  PAIN  SCALE: This  measures  pain  as  a  physiological 
variable, blood pressure along with behavioral changes. This has been shown to be a 
sensitive and reliable tool in evaluating postoperative pain in children who are not 
able to verbally comment upon their pain experience. This takes into account the 
systolic blood pressure, cry and it’s response to love and care, movement, agitation 
and verbal evaluation as described by Hannallah RS. (18)
                                 TABLE -1: OBJECTIVE PAIN SCALE
                                                 TLC -   TOUCH, LOVE AND CARE
–TABLE-II MODIFIED ALDRETE’S SCORE
TABLE III: RAMSAY SEDATION SCORE
Six point sedation score was assigned as follows
SCORE CLINICAL DESCRIPTION
I          Anxious, Agitated 
II
     
Cooperative, Oriented, Tranquil
III
       
Responds only to verbal commands
IV
      
Asleep with brisk response to light stimulation
V
    
Asleep with sluggish response to stimulation
     
VI Asleep without response to stimulation

MATERIALS AND METHODS
The study population consisted of 60ASA I and II Children in the age group of 2 
years  to  8  years  admitted  to  undergo  elective  lower  abdominal  general  surgical 
procedure at our hospital. 
Exclusion  criteria  consisted  of  local  infection  in  the  caudal  region,  bleeding 
diathesis,  preexisting  neurological  or  spinal  diseases  and  congenital  anomaly  of  the 
lower back. The study was approved by the institutional ethics committee. 
A written consent was obtained from the parents after they were informed about 
the procedure to be performed, to give postoperative analgesia to their child.
All Children were kept fasting (NPO for 6 hours) and unpremedicated. They were 
received by an anaesthesiologist inside the operating room half an hour before surgery. 
Thereafter, baseline cardio respiratory parameters such as pulse rate, systolic blood 
pressure, ECG, respiratory rate and (SpO2) were  recorded and monitored continuously 
until extubation.
Anaesthesia was induced by inhalation of halothane at increasing concentrations in N2O 
and  oxygen  mixture.  Intravenous  line  secured  after  achieving  adequate  depth  of 
anaesthesia.
  Thiopentone  was  used  as  the  induction  agent.Orotracheal  intubation  was 
performed  with  an  appropriate  size  uncuffed  endotracheal  tube.  No  opioids  or 
benzodiazepines were used intraoperatively.
 Under controlled ventilation, muscle relaxation was maintained with atracurium. 
The patients were placed in left lateral position with hips and knees flexed. 
The children were allocated into two groups of each 30 patients
Group B:  0.25% bupivacaine alone
Group BN. 0.25% bupivacaine with 2µg/kg neostigmine
The dosage of local anaesthetic injected into the caudal space was calculated according 
to the ARMITAGE formula.
A 22G hypodermic needle was inserted in the hiatus at 45° angle to the skin. Once the 
sacrococcygeal membrane was penetrated and loss of resistance obtained, the angle of 
the needle was changed and directed up the canal for further 0.5 cm. The injection was 
made after gentle aspiration to rule out any intrathecal and intravascular placement. 
General  anaesthesia  was  maintained  with  halothane  and  60% nitrous  oxide  in  40% 
oxygen. 
The surgical incision was made 20 min after administering caudal block during 
which  time  the  children  were  surgically  prepared  and  draped.    Adequate  caudal 
analgesia was defined as haemodynamic stability as indicated by absence of increase in 
heart rate and systolic BP of more than 15% compared with basal values obtained just 
before surgical incision with halothane concentration maintained at 1%. 
If systolic BP >15% increase occurred analgesia was considered inadequate and 
rescue opioids fentanyl given at the dosage of 2µg/kg.Intraoperative fluid management 
was taken care by using HOLIDAY AND SEGAR formula. 
postoperatively the Children were shifted to the recovery room for  continuous 
monitoring. Postoperative sedation score was done using RAMSAY SCALE every one 
hour for first 6 hours and then every 2 hours 
The  recovery  was  assessed  using  Modified  Aldrete  Score the  children  were 
shifted to a dedicated postoperative ward where monitoring of respiratory rate,  (SpO2), 
pulse  rate and systolic  blood pressure  were continued.  The quality  of  analgesia  was 
assessed hourly for first 6 hours and then every 2 hours. 
The  intensity  of  pain  was  measured  using  the  Objective  Pain  Scale  Score 
devised by Hannallah RS. Each parameter was awarded a score of 0-2 accordingly. The 
sum total of the awarded score was taken at each time interval. A log was kept at the 
bedside  for  noting  the  occurrence  of  possible  complications  including,  hypotension, 
urinary retention, nausea and vomiting.
 Patients were administered rescue analgesia with syrup paracetamol 10 mg/Kg on 
evidence of pain that is if the OPS reached a value of 5.  The time of first analgesia 
(TFA) was calculated from the time of injection of the drug in the epidural space to the 
time when OPS reached 5.
 Respiratory depression was defined as decrease of (SpO2) < 93% or a decrease in 
RR < 10 /min. Excessive sedation was defined as a RAMSAY SEDATION SCORE of 
V or VI. 
Urinary retention was defined as inability to void urine for a period of at least 8 hours.
           Caudal block and monitoring of scores for pain, nausea and vomiting and 
sedation were performed by anaesthesiologists blinded to the study allocations.
 OBSERVATION AND ANALYSIS
Sixty patients posted for elective lower abdominal general surgical procedure who 
were  admitted  in  the  Department  of  paediatric  surgery,  RAJA  MIRASUDHAR 
HOSPITAL, THANJAVUR MEDICAL COLLEGE of  physical  status  ASA I and II 
were taken up for the study. They were randomly divided into two groups of 30 patients 
each to receive caudal block as mentioned below.
One group (group BN) received a mixture of Bupivacaine 0.25% and neostigmine 
at  2µg/kg,  20  minutes  before  surgery.  Other  group  (group  B)  received  0.25% 
Bupivacaine alone 20 minutes before surgery. The patients were assessed by a blinded 
observer in the postoperative period.
AGE AND SEX DISTRIBUTION
The age distribution in both groups ranged from 2 – 8 years .The age and sex 
distribution is as follows
From this table it is clear that the number of children in 24-48, 48-72,       and 72-96 
month interval are not much different between the two groups. This shows age was not a 
confounding factor. 
AGE DISTRIBUTION
             FIG -2
In this bar diagram, the horizontal axis represents age in years and vertical 
axis represents the number of patients. Although there are more children in the  (1-4yrs) 
in B group the distribution among the two study group is almost the same.
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36.7
86.7
100
AGE B
Frequency Percent Valid percent Cumulative 
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     Total
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100
                                                    FIG -3
In group B 66.7% are male and 33.3% are female and in group
BN 73.3% are male and 26.7 % are female. The sex distribution in both 
the group is also not much different. Hence there is no bias in the age 
and sex distribution .
SEX DISTRIBUTION
N
O
O
F
P
A
T
I
E
N
T
S
20
22
8
10
0
5
10
15
20
25
GROUP B GROUP BN
MALE FEMALE
SEX B
Frequency Percent Valid percent Cumulative 
percent
Valid 
 Male 
Female 
Total
20
10
30
66.7
33.3
100
66.7
33.3
100
66.7
100
SEX BN
Frequency Percent Valid percent Cumulative 
percent
Valid 
Male 
Female 
Total
22
8
30
73.3
26.7
100
73.3
26.7
100
73.3
100
TYPES OF SURGICAL PROCEDURES
The various surgical procedures performed are shown below
SURGICAL 
PROCEDURES
GROUP B GROUP BN
     Herniotomy
     PV sac ligation
     Hypospadias
15
8
7
15
5
10
Total 30 30
From this table it is clear that the type of surgical procedures between the two groups is 
not much different. Hence there is no bias in the type of surgical procedures.
DURATION OF ANALGESIA
Duration of analgesia in group B (0.25% bupivacaine) range from 3. to 5 hours with a 
mean duration of 4.3 hours. 
In group BN (0.25 % Bupivacaine + 2 µg/Kg Neostigmine) the duration of analgesia 
ranged from 10 to 16 hours with a mean duration of 14.6 hours. 
DURATION OF 
ANALGESIA
GROUP B GROUP BN
Range 3-5 10-16
Mean 4.3 14.6
Standard Deviation 0.75 1.52
.
DURATION OF ANALGESIA
,                                                 FIG -4
The mean duration of analgesia in group BN is 14.6 hours, whereas in group B it 
is only about 4.3 hours. This means that group BN has got extended duration of 
analgesia when compared with group B.
This duration of analgesia is also statistically significant as detected by using One 
sample T test by which the probability value is less than 0.05 (P value < 0.0005). This P 
value means that it is highly significant.
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SIDE EFFECTS
NAUSEA AND VOMITING
One patient  in  group B had nausea  and vomiting  (3.3%)  when  compared with  two 
patients in group BN (6.6 %). 
There was no significant difference in the incidence of urinary retention between the two 
groups. 
No  side  effects  like  hypotension,  respiratory  depression  or  apnea  was  seen  in  any 
patient. Overall side effects did not differ between the two groups. 
SIDE EFFECTS
Side effects Group B Group BN
Nausea and vomiting
Urinary retention
Hypotension
1
1
0
2
1
0
                                
                   
   FIG -6 SIDE EFFECTS
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STATISTICS
DURATION OF ANALGESIA B
Frequency Percent Valid percent Cumulative 
percent
Valid   3
           4
           5
Total
5
11
14
13
16.7
36.7
46.7
100
16.7
36.7
46.7
100
16.7
53.3
100
AGE B SEX B Cross tabulation
Count
SEX B
MALE FEMALE
TOTAL
AGE GROUP B  <4
                            5-6
                           7-8 
Total 
11
5
4
20
6
3
1
10
17
8
5
30
   
AGE BN SEX BN Cross tabulation
Count
SEX BN
MALE FEMALE
TOTAL
AGE GROUP BN  <4
                                5-6
                               7-8
9
11
2
2
4
2
11
15
4
                              Total 22 8 30
FREQUENCIES
Statistics
Gp B
Analgesia
Gp BN
Analgesia
Wt
Gp B
Wt
Gp BN
Age
Gp B
Age
Gp BN
N        Valid
           Missing
Mean
Median
Std.Deviation
30
0
4.3
4
0.75
30
0
14.6
15
1.52
30
0
21.33
24
5.79
30
0
23.87
26
4.76
30
0
4.43
4
1.85
30
0
5
5
1.6
T-Test One sample statistics
N Mean Std.Deviation Std.error 
mean
Gp BN
Analgesia
Gp B
Analgesia
30
30
14.6
4.3
1.52
0.75
0.28
0.14
Here the mean time in the BN group (14.6 hrs) is higher than the group B(4.3).When we 
take the mean value of B group as test value and compare it with BN group the 
difference in the mean observed is statistically significant P<0.0005) with a 99% CI 0f 
9.53 to 11.07.
One sample T Test
Test Value=4.3
t Df
Sig
.(2-tailed)
Mean 
difference
99% Confidence 
interval of the 
difference
Lower Upper
Gp BN
Analgesia
37.061 29 .0  .000 
0
10.30 9.53 11.07
ABOUT ONE SAMPLE T TEST
 The one sample T test procedure test whether the mean of a single variable differs 
from a specified constant.
A low significant value typically below 0.05 indicates that there is a significant 
difference between the test value and the observed mean. (Sig 2 tailed-4th column)
If the confidence interval for the mean difference does not contain the zero, this 
also indicates that the difference is significant. (99% CI Between 9.53-11.07 there is no 
zero hence the difference observed is significant)
(If the significant value is high and the confidence interval for the mean difference 
contain zero then you can’t conclude that there is a significant difference between the 
test value and the observed mean)This is not the case in this study hence the result 
observed is significant.
Conclusion: The duration of analgesia of BN group is higher (14.6hrs) when compared 
to the B group (4.3 hrs) and the difference is also statistically significant (P<0.0005).
REVIEW OF LITERATURE
Caudal block is a simple and safe technique, which can be routinely adopted in 
children. This provides effective intraoperative and postoperative analgesia for almost 
all  types  of  interventions  on  the  lower  part  of  the  abdomen  and  the  lower  limbs, 
especially in the neonates, infants and certain high risk children as per the experience of 
ARMITAGE EN AND ARTHUR DS.
The  success  rate  was  found  to  be  94.5%  as  per  the  experience  of  ARMANDO 
FORTUNA (22)
Caudal anaesthesia is usually but not always combined with a light general anaesthesia 
with halothane followed by isoflurane either at the beginning or, sometimes, at the end 
of surgical procedure. DALENS B, HASNAOUI A (23)
The timing of caudal block placement in relation to surgery does not affect duration of 
post operative analgesia in paediatric ambulatory patients as evidenced by  RICE LJ, 
PUDIMAT MA, and HANNALLAH RS (24)
HANNALLAH RSet al(25) conducted a study in children in the age group of 18 
months to 12 years scheduled for orchiopexy to evaluate the effectiveness of caudal 
analgesia and compared it with local nerve blocks. They found that both caudal as well 
as Ilioinguinal / Iliohypogastric nerve blocks administered following inhaled anaesthesia 
for orchiopexy are safe and equally effective in controlling post operative pain of 
children.
GUNTER et al(27) conducted a study on 122 children aged 1 to 8 years scheduled for 
out patient inguinal herniorhaphy who were randomized to receive in a double blind 
fashion caudal anaesthetic with bupivacaine in one of the six concentrations (0.125%, 
0.15%, 0.175%, 0.2% and 0.25%). After incision a programmed reduction in inspired 
halothane resulted, if tolerated by the subject. Although all concentrations were effective 
for  combined  general  caudal  anaesthesia  in  children,  they  concluded  that  0.175% 
bupivacaine offers the best combination of effectiveness, rapid recovery and discharge 
for   paediatric surgical outpatients without any motor blockade.
In another study by WOLF AR et al (28) on 114 infants and children of age 6 months to 
10 years, undergoing elective superficial lower abdominal or genital surgery to find the 
optimum concentration  of  bupivacaine  for  caudal  analgesia,  concluded  that  0.125% 
bupivacaine  with  1  in  200,000  adrenaline  provided  equipotent  analgesia  and 
significantly less motor blockade than 0.25% bupivacaine.
Eisenach et al (41) demonstrated that acetylcholine has intrinsic analgesic properties, 
and that the concentration of acetylcholine in CSF is increased during painful electrical 
stimulation. They further suggested that enhanced amounts of acetylcholine released 
from  preganglionic sympathetic neurons after spinal neostigmine administration may 
counteract the sympatholytic actions of local anaesthetics or 2-agonists (reducing the 
degree of hypotension) and add a synergistic antinociceptive effect to spinal 2-agonists. 
Abdullatif  and EL-Sanabary  (45) -  A study  in  the  children  compared three 
groups to determine the effectiveness of neostigmine 2µg/kg as a caudal analgesic for 
hypospadiasis repair, either alone or in combination with bupivacaine.The combination 
of bupivacaine and neostigmine provided superior analgesia to either of the other two 
groups and mean duration of 22..8 hrs compared with 8.1 hrs in the bupivacaine plain 
group and 5.2hrs in the neostigmine plain group.
Batra YK, et al (47) evaluated for the first time the efficacy of a varying dose of caudal 
neostigmine for postoperative analgesia in children undergoing genitourinary surgery. 
studied 120 children age group of 2-8 years scheduled for surgical repair of hypospadias 
under  general  anaesthesia:Caudal  neostigmine  in  the  dose  range  of  20-50  µg.kg(-1) 
provides dose dependent analgesia. However, dose exceeding 30 µg.kg(-1) is associated 
with a higher incidence of nausea and vomiting.
Ping-Heng  Tan, et  al (56) investigated  the  value  of  Intrathecal  bupivacaine  with 
morphine  or  neostigmine  for  postoperative  analgesia  after  total  knee  replacement 
surgery 
 Sixty patients scheduled for elective total knee replacement under spinal anaesthesia 
were  randomly  divided  into  three  equal groups  which  received  intrathecal  0.5% 
hyperbaric bupivacaine 15 mg with either normal saline 0.5 mL, neostigmine 50 µg, or 
morphine 300 µg.. Overall satisfaction rates were better in the neostigmine group than in 
the morphine and saline groups (P <0.05).  Intrathecal   neostigmine 50 µg produced 
postoperative analgesia  lasting  about  seven  hours  with  fewer  side  effects and  better 
satisfaction  ratings  than  intrathecal   morphine  300  µg. Rajesh  Mahajan,et  al (5) 
evaluate the analgesic efficacy and duration of varying doses of caudal neostigmine with 
plain bupivacaine and its side effects in children undergoing genito-urinary surgery. In a 
randomized double-blind prospective study 80 boys aged two to eight years scheduled 
for surgical repair of hypospadias were allocated randomly to one of four groups (n = 20 
each) and received either only caudal 0.25% plain bupivacaine 0.5 mL·kg–1 (Group I) or 
0.25% plain bupivacaine 0.5 mL·kg–1 with neostigmine (Groups II–IV) in doses of 2, 3 
and 4 µg·kg–1 respectively. The duration of postoperative analgesia in Group I (5.1 ± 2.3 
hr) was significantly shorter than in the other three groups (II –16.6 ± 4.9 hr; III – 17.2 ± 
5.5 hr; IV – 17.0 ± 5.8 hr;  P < 0.05). Total analgesic (paracetamol) consumption was 
significantly more in Group I (697.6 ± 240.7 mg) than in the groups receiving caudal 
neostigmine (II – 248.0 ± 178.4; III – 270.2 ± 180.8 and IV –230.6 ± 166.9 mg;  P < 
0.05). Groups II, III and IV were comparable with regards to duration of postoperative 
analgesia and total analgesic consumption (P > 0.05). Incidence of nausea and vomiting 
were comparable in all four groups. No significant alteration in vital signs or any other 
adverse effects were observed. Caudal neostigmine (2, 3 and 4 µg·kg–1) with bupivacaine 
produces a dose-independent analgesic effect ( 16–17 hr) in children as compared to 
those receiving caudal bupivacaine alone (approximately five hours) and a reduction in 
postoperative rescue analgesic consumption without increasing the incidence of adverse 
effects. 
Rudra  A.et  al  (57)  examined  the  analgesic  efficacy  of  caudal  administration  of 
bupivacaine or a mixture of bupivacaine-neostigmine in 40 children (ASAI), undergoing 
inguinal  herniotomy or  orchidopexy.  They were randomly allocated into two groups 
(n=20), to receive a caudal injection
of  either  0.25%  bupivacaine  with  or  without  neostigmine  2  µgkg-1.  Time  to  first 
analgesic  administration  (paracetamol  suppository)  was  longer  (p<0.05)  in  the 
bupivacaine-neostigmine than in the other group. Side effects such
as emesis was not significantly different between the two groups. We conclude that a 
single caudal co-administration of the two drugs is associated with extended duration of 
postoperative analgesia.
Lauretti et al (46) Studied Epidural neostigmine (1, 2, or 4 microg/kg) in lidocaine 
produced a dose-independent analgesic effect (approximately 8 h) compared to the 
control group (approximately 3.5 h), and a reduction in postoperative rescue analgesic 
consumption without increasing the incidence of adverse effects.
Mahajan,et al(5) in their study evaluate the Caudal neostigmine (2, 3 and 4 µg·kg–1) 
with bupivacaine produces a dose-independent analgesic effect ( 16–17 hr) in children 
as compared to those receiving caudal bupivacaine alone (approximately five hours) and 
a  reduction in  postoperative  rescue  analgesic  consumption  without  increasing the 
incidence  of  adverse  effects. 
DISCUSSION
The present study demonstrated that caudal neostigmine in a dose of 2 µg/kg co-
administered with bupivacaine 0.25% markedly prolonged postoperative analgesia and 
reduced the need for oral paracetamol in children undergoing lower abdominal surgeries. 
The  study  conducted  by  Mahajan (5) and  coworkers  which  reported  a  mean 
duration of 16.6 ± 4.9 hours, was well correlated with our study. The mean duration of 
postoperative analgesia in our study Group BN is (14.6 hours). This value is statistically 
significant as detected by one sample T- Test by which the probability value is less than 
0.05 (P <0.0005), which means that it is highly significant. In the present study, we have 
confirmed  the  analgesic  efficacy of  caudal  neostigmine  when  co-administered  with 
bupivacaine.
The neuraxial  administration of  neostigmine is  known to produce analgesia  in 
animals,  human  volunteers  and  patients  with  acute postoperative  and  chronic  pain. 
Spinal delivery of the cholinesterase inhibitor neostigmine inhibits the breakdown of the 
endogenous  spinal  neurotransmitter  acetylcholine  which has  been  shown to  produce 
analgesia. Eisenach et al (40)
Neuraxial  administration of  neostigmine  increases  the  concentration  of 
acetylcholine in cerebrospinal fluid and produces antinociception in animals which is 
blocked by the intrathecal administration of a muscarinic antagonist. The analgesic effect 
is thought to be mediated via spinal muscarinic M1 receptors and supraspinal muscarinic 
M1 and M2 and nicotinic cholinergic receptors.
Various  investigators  have reported a  dose-independent  effect of the neuraxial 
administration of neostigmine on postoperative pain relief and analgesic requirements. In 
pregnant  patients Krukowski  et  al.  (32) have  demonstrated  that  varying  doses  of 
intrathecal (10,  30  and  100  µg)  provided  dose  independent  analgesia lasting 
approximately ten hours in all three groups. 
Similarly Lauretti et al. (39) have shown dose independent analgesia in patients 
undergoing vaginal hysterectomy in a dose range of 25 to 75 µg intrathecal neostigmine. 
The  same  authors  have  also demonstrated  dose  independent  analgesia  with  the 
combination of  20  mg  intrathecal  bupivacaine  plus  85  mg  epidural  lidocaine with 
neostigmine (1, 2 or 4 µg·kg–1) in patients undergoing knee surgery Lauretti et al. (38).
The lowest dose of neostigmine may have maximally potentiated the analgesic 
effect  of  caudal  bupivacaine,  making  higher  doses  of  caudal neostigmine  no  more 
effective. Considering the lack of efficacy of neostigmine alone in doses < 10 µg·kg–1, 
Batra YK, et al (47). It is not surprising that lower doses combined with bupivacaine 
may have uniformly potentiated the effect of caudal bupivacaine.
Although  the  use  of  neuraxial  neostigmine  has  been  associated with 
gastrointestinal side effects such as nausea and vomiting, these were encountered very 
minimally in the present study. Lauretti  et al (46) and  Roelants  et al. (62) have also 
reported the extradural administration of neostigmine to be devoid of these undesirable 
side effects. Further, these side effects have been found to be statistically insignificant 
(Abdullatif  and  EL-Sanabary(45)- and  independent  of  the dose  of  neuraxial 
neostigmine Lauretti et al (46) . The use of caudal bupivacaine alone has been found to 
be associated with nausea and vomiting to the extent of 25 to 45%, Wolf AR, (63) an 
incidence similar to that seen with caudal morphine, fentanyl and tramadol. SenelAC 
(59),Krane EJ, (60) ,Gaitini LA(61) It seems that caudal neostigmine in such low doses 
contributes minimally to nausea and vomiting. 
Caudal  neostigmine  is  effective as  a  sole  analgesic with duration of  analgesia 
comparable  to  that  reported  with caudal  bupivacaine  0.25%. Abdullatif  and  EL-
Sanabary(45). In  line  with  the  findings  of  the present  study,  co-administration  of 
neostigmine  with  bupivacaine  significantly  extended  the  duration  of  postoperative 
analgesia.
The duration of analgesia in Group BN ranged from 10-16 hours was comparable 
to results obtained by Rudra et al (57) ranged between 19±4.2 hours.
These  results  were  also  correlated  well  with  the  study  results  obtained  by 
Abdullatif and EL-Sanabary(45). That combination of bupivacaine and neostigmine 
provides  superior  analgesia  than  to  bupivacaine  alone  with  the  mean  duration  of 
22.8±2.9 hours.In their study they had used 1 ml/kg of bupivacaine ,but in our study we 
used  only  0.5ml/kg  of  bupivacaine,so  that  might  be  a  reason  for  difference  in  the 
duration of analgesia.  
The incidence of nausea and vomiting in Group BN is 6.6%. this was comparable 
to the results obtained by Rudra et al(57) and Mahajan (5) coworkers who reported the 
incidence was less than 20%.
In this study, in spite of using a smaller dose of  neostigmine (2µg/kg) the mean 
duration  of  analgesia  was  14.6  hours,  which  could  due  to  synergistic  effect  of 
bupivacaine and neostigmine.
SUMMARY
In a randomized double blind study, we have examined the analgesic efficacy of 
caudal  bupivacaine  alone  or  a  mixture  of  bupivacaine-neostigmine  in  sixty  children 
(ASA I, II), aged 2-8 yrs undergoing lower abdominal surgeries. They were randomly 
allocated into two groups (n -30) to receive a caudal injection of 0.25% bupivacaine 
alone or a mixture of 0.25% bupivacaine 0.5ml/kg with 2µg/kg neostigmine.Monitoring 
of  scores  for  pain,  post  operative  nausea  and  vomiting  was  performed  by  an 
anaesthesiologist  blinded  to  the  study  allocations.  Time  to  the  first  analgesic 
administration(sy.Paracetamol )was longer (P<0.05) with mean duration of analgesia of 
14.6 hrs in the bupivacaine-neostigmine than in the bupivacaine only group with a mean 
duration of 4.3hrs.Side effect such as emesis was not significantly different between the 
two  groups.  We  conclude  that  a  caudal  co  administration  of  bupivacaine  with 
neostigmine  produces  significant  prolongation  of  the  duration  of  post  operative 
analgesia when compared to caudal bupivacaine only.
CONCLUSION
We  conclude  that  caudal  epidural  analgesia  using  a  combination  of  0.25% 
bupivacaine 0.5ml/kg and neostigmine (2µg/kg) significantly prolong the postoperative 
analgesia  when compared to  0.25% bupivacaine alone in  children undergoing lower 
abdominal general surgical procedures without any significant increase in side effects.
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ANNEXURES
FLACC Behavioural pain scale:
FLACC Behavioral Pain Assessment
Categories 0
Scoring
1 2 
Face No particular expression or smile Occasional grimace or frown, withdrawn, disinterested
Frequent to constant quivering 
chin, clenched jaw
Legs Normal position or relaxed Uneasy, restless, tense Kicking, or legs drawn up
Activity Lying quietly, normal position moves easily
Squirming, shifting back and forth, 
tense Arched, rigid or jerking
Cry No cry, (awake or asleep)
Moans or whimpers; occasional 
complaint
Crying steadily, screams or sobs, 
frequent complaints
Consolability Content, relaxed
Reassured by occasional touching 
hugging or being talked to, 
distractable
Difficulty to console or comfort
Each of the five categories is scored from 0-2, resulting in a total score between 0 and 10.
The FLACC scale was developed by Sandra Merkel, MS, RN, Terri Voepel-Lewis, MS, RN, and Shobha Malviya, MD, at C. S. Mott Children’s Hospital, University of Michigan Health System, Ann 
Arbor, MI.
Copyright © 2002, The Regents of the University of Michigan. Reproduced with permission. 
Children's Hospital Eastern Ontario Pain Scale (CHEOPS)
(Recommended for children 1-7 years old) - A score greater than 4 indicates pain.
Item Behavioral   Definition Score 
Cry No cry 1 Child is not crying.   
  Moaning 2 Child is moaning or quietly vocalizing silent cry.   
  Crying 2 Child is crying, but the cry is gentle or whimpering.   
  Scream 3 Child is in a full-lunged cry; sobbing; may be scored with complaint or without complaint.   
Facial Composed 1 Neutral facial expression.   
  Grimace 2 Score only if definite negative facial expression.   
  Smiling 0 Score only if definite positive facial expression.   
Child Verbal None 1 Child not talking.   
  Other complaints 1 Child complains, but not about pain, e.g., “I want to see mommy” of “I am thirsty”.   
  Pain complaints 2 Child complains about pain.   
  Both complaints 2 Child complains about pain and about other things, e.g., “It hurts; I want my mommy”.   
  Positive 0 Child makes any positive statement or talks about others things without complaint.   
Torso Neutral 1 Body (not limbs) is at rest; torso is inactive.   
  Shifting 2 Body is in motion in a shifting or serpentine fashion.   
  Tense 2 Body is arched or rigid.   
  Shivering 2 Body is shuddering or shaking involuntarily.   
  Upright 2 Child is in a vertical or upright position.   
  Restrained 2 Body is restrained.   
Touch Not touching 1 Child is not touching or grabbing at wound.   
  Reach 2 Child is reaching for but not touching wound.   
  Touch 2 Child is gently touching wound or wound area.   
  Grab 2 Child is grabbing vigorously at wound.   
  Restrained 2 Child's arms are restrained.   
Legs Neutral 1 Legs may be in any position but are relaxed; includes gentle swimming or separate-like movements.   
  Squirm/kicking 2 Definitive uneasy or restless movements in the legs and/or striking out with foot or feet.   
  Drawn up/tensed 2 Legs tensed and/or pulled up tightly to body and kept there.   
  Standing 2 Standing, crouching or kneeling.   
  Restrained 2 Child's legs are being held down.   
